Skip to main content

Schott, Alpha Innotech, Genomic Solutions Form Unofficial Co-Marketing Alliance

BOSTON, Sept. 15 (GenomeWeb News) - German slide and microtiter plate vendor Schott-Nexterion has teamed up with Genomic Solutions and Alpha Innotech to form an "unofficial collaboration" that enables the three companies to fuse their products in presentations to customers as "an integrated [product offering] for doing multiplexed assays," officials from the three firms said yesterday.


The technologies involved in the alliance are Schott's slides and plates, GS' MicroGrid array spotters, and Alpha Innotech's NovaRay reader.


Speaking at IBC's Chips to Hits Conference here this week after a presentation by a Genomic Solutions partner who described the alliance, Schott-Nexterion general manager Lutz Wehmeier said that the collaboration aims to "enhance [the platforms' ability to] work together to produce a very dedicated format."


"[Our] companies [think] that the microtiter format will be very important" in clinical diagnostics, Wehmeier said. While the collaboration is non-exclusive, Schott will recommend Genomic Solutions and Alpha Innotech tools to their customers, Wehmeier said.


Wehmeier did not exclude the possibility of a formal co-marketing agreement with the two companies. "We will evaluate future opportunities for co-marketing seriously," he said.


Sia Ghazvini, vice president of business development at Alpha Innotech, told GenomeWeb News that the companies chose to collaborate together because they viewed each other as the strongest in their respective areas in the microtiter space, and that the collaboration was focused on making the plate format easier to access and understand for customers.


During his presentation, Jeremy Clarke, Genomic Solutions' global product manager, also revealed that the trio has working with the Universityof Arizonaand StanfordUniversity, and both are helping them develop assays based on their respective equipment.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.